Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-664,924
Closed -$111M 31
2016
Q3
$111M Hold
664,924
4.82% 4
2016
Q2
$101M Sell
664,924
-23,900
-3% -$3.72M 4.66% 5
2016
Q1
$103M Sell
688,824
-14,700
-2% -$2.18M 4.96% 5
2015
Q4
$114M Buy
703,524
+104,800
+18% +$16.5M 5.33% 5
2015
Q3
$82.7M Buy
+598,724
New +$94.4M 3.89% 8
2014
Q1
Sell
-559,224
Closed -$63.8M 39
2013
Q4
$63.8M Buy
+559,224
New +$63.6M 3.33% 10
2013
Q3
Sell
-432,224
Closed -$42.6M 29
2013
Q2
$42.6M Buy
+432,224
New +$44.9M 2.58% 14

Other funds holding AMGN

Alliance Trust's AMGN Position: Q4 2016 in Review

Alliance Trust sold out of Amgen (AMGN) in Q4 2016, closing a stake of 664,924 shares — an estimated $111M sold.

Alliance Trust first reported a position in AMGN in Q2 2013 and held it in 7 quarters. The position peaked at $114M in Q4 2015. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • Alliance Trust reported no remaining Amgen position as of Q4 2016 after selling out during the quarter.
  • Alliance Trust sold 664,924 Amgen shares in Q4 2016, an estimated $111M.
  • Alliance Trust first reported a position in Amgen in Q2 2013 and held it in 7 quarters.
  • Alliance Trust's Amgen position peaked at $114M in Q4 2015.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on Alliance Trust's 13F filing for Q4 2016, filed 7 Feb 2017.